Maślanka Krystyna, Zupańska Barbara
Instytut Hematologii i Transfuzjologii w Warszawie, Zakład Immunologii Hematologicznej i Transfuzjologicznej.
Pol Merkur Lekarski. 2006 Jun;20(120):660-3.
Post-transfusion purpura (PTP), a delayed post-transfusion event, is underdiagnosed, not only in Poland. Thrombocytopenia results from the destruction of patients' and transfused platelets by platelet specific antibodies (anti-HPA). The incidence of PTP is not estabilished.
Analysis of 10 cases with PTP diagnosed in Poland during last 25 years.
9 women and 1 man with normal platelet count who developed thrombocytopenia with diathesis haemorrhagica after transfusion of red cells or/and platelets. Platelet specific antibodies (anti-HPA) were examined by the platelet immunofluorescence test and by the monoclonal immobilization of platelet antibodies (MAIPA) assay; leucocyte antibodies by standard lymophocytotoxicity test (LCT).
In all 10 patients the PTP was diagnosed because: 1) thrombocytopenia with diathesis haemorrhagia occured 3-10 days after the transfusion (in 5 cases blood was transfused during the operation), 2) in all the patients anti-HPA were detected (in 9- anti-HPA-1a, in 1 case anti-HPA-3a), 3) a primary HPA alloimmunization was very probable. A recovery of platelets count occured in 6 patients within 8-34 days after corticosteroids and/or IVIG, however, therapeutic effect of them was difficult to assess due to a great probability of spontaneous remission up to 1 month. Four patients died due to their basic disease although the impact of the PTP cannot be excluded.
The diagnosis of PTP was possible because of the detection of anti-HPA antibodies in patients who developed thrombocytopoenia after blood transfusion.
输血后紫癜(PTP)是一种输血后延迟发生的事件,不仅在波兰,其诊断率都较低。血小板减少是由血小板特异性抗体(抗-HPA)破坏患者自身及输入的血小板所致。PTP的发病率尚未确定。
分析过去25年在波兰诊断的10例PTP病例。
9名女性和1名男性,血小板计数正常,在输注红细胞或/和血小板后出现血小板减少并伴有出血倾向。通过血小板免疫荧光试验和血小板抗体单克隆固定试验(MAIPA)检测血小板特异性抗体(抗-HPA);通过标准淋巴细胞毒性试验(LCT)检测白细胞抗体。
所有10例患者均诊断为PTP,原因如下:1)输血后3 - 10天出现血小板减少并伴有出血倾向(5例在手术期间输血);2)所有患者均检测到抗-HPA(9例为抗-HPA-1a,1例为抗-HPA-3a);3)很可能为原发性HPA同种免疫。6例患者在使用糖皮质激素和/或静脉注射免疫球蛋白后8 - 34天血小板计数恢复,但由于在1个月内很可能自发缓解,故难以评估其治疗效果。4例患者因基础疾病死亡,尽管不能排除PTP的影响。
对于输血后出现血小板减少的患者,通过检测抗-HPA抗体可以诊断PTP。